{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:00:03Z","timestamp":1785780003873,"version":"3.56.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011268.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000}}],"reference-count":52,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011268.pub3","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T23:40:21Z","timestamp":1552952421000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Second-generation antidepressants for preventing seasonal affective disorder in adults"],"prefix":"10.1002","volume":"2019","author":[{"given":"Gerald","family":"Gartlehner","sequence":"first","affiliation":[{"name":"Danube University Krems; Cochrane Austria, Department for Evidence-based Medicine and Clinical Epidemiology; Dr.-Karl-Dorrek-Strasse 30 Krems Austria 3500"},{"name":"RTI International; Research Triangle Park North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Nussbaumer-Streit","sequence":"additional","affiliation":[{"name":"Danube University Krems; Cochrane Austria, Department for Evidence-based Medicine and Clinical Epidemiology; Dr.-Karl-Dorrek-Strasse 30 Krems Austria 3500"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley N","family":"Gaynes","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill; Department of Psychiatry; CB# 7160 Chapel Hill North Carolina USA 27599-7160"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A","family":"Forneris","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill; Department of Psychiatry; CB# 7160 Chapel Hill North Carolina USA 27599-7160"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C","family":"Morgan","sequence":"additional","affiliation":[{"name":"IBM Watson Health; 15 Dartford CT Chapel Hill North Carolina USA 27517"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Greenblatt","sequence":"additional","affiliation":[{"name":"Emory University; Nell Hodgson Woodruff School of Nursing; Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Wipplinger","sequence":"additional","affiliation":[{"name":"Danube University Krems; Department for Evidence-based Medicine and Clinical Epidemiology; Dr.-Karl-Dorrek-Stra\u00dfe 30 Krems Austria 3500"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda J","family":"Lux","sequence":"additional","affiliation":[{"name":"RTI International; Research Triangle Park North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan G","family":"Van Noord","sequence":"additional","affiliation":[{"name":"University of California Davis; Carlson Health Sciences Library; Davis California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Winkler","sequence":"additional","affiliation":[{"name":"Medical University of Vienna; Department of Psychiatry and Psychotherapy; Waehringer Guertel 18-20 Vienna Austria 1090"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"10.1002\/14651858.CD011268.pub3-BIB0001|cit1","unstructured":"GlaxoSmithKline A 7-month, multicenter, randomized, double-blind, placebo-controlled comparison of 150-300mg\/day of extended-release bupropion hydrochloride (WELLBUTRIN XL) and placebo for the prevention of seasonal affective disorder in subjects with a history of seasonal affective disorder followed by an 8-week observational follow-up phase GSK - Clinical Study Register [www.gsk-clinicalstudyregister.com] 2003"},{"issue":"8","key":"10.1002\/14651858.CD011268.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.biopsych.2005.07.021","article-title":"Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL","volume":"58","author":"Modell","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0003|cit3","unstructured":"GlaxoSmithKline A 7-month, multicenter, randomized, double-blind, placebo-controlled comparison of 150-300mg\/day of extended-release bupropion hydrochloride (WELLBUTRIN XL) and placebo for the prevention of seasonal affective disorder in subjects with a history of seasonal affective disorder followed by an 8-week observational follow-up phase GSK - Clinical Study Register [www.gsk-clinicalstudyregister.com] 2003"},{"issue":"8","key":"10.1002\/14651858.CD011268.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.biopsych.2005.07.021","article-title":"Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL","volume":"58","author":"Modell","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0005|cit5","unstructured":"GlaxoSmithKline A 7-month, multicenter, randomized, double-blind, placebo-controlled comparison of 150-300mg\/day of extended-release bupropion hydrochloride (WELLBUTRIN XL) and placebo for the prevention of seasonal affective disorder in subjects with a history of seasonal affective disorder followed by an 8-week observational follow-up phase GSK - Clinical Study Register [www.gsk-clinicalstudyregister.com] 2004"},{"issue":"8","key":"10.1002\/14651858.CD011268.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.biopsych.2005.07.021","article-title":"Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL","volume":"58","author":"Modell","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1600-0447.2003.00256.x","article-title":"Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study","volume":"109","author":"Martiny","year":"2004","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0006-3223(98)00252-2","article-title":"Prophylactic treatment of seasonal affective disorder (SAD) by using light visors: bright white or infrared light?","volume":"46","author":"Meesters","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0009|cit9","first-page":"S7","article-title":"Light treatment of seasonal affective disorder in combination with citalopram or placebo with 1-year follow-up","volume":"14 Suppl 2","author":"Thorell","year":"1999","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0010|cit10","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0011|cit11","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0012|cit12","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (text revision)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0013|cit13","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"2","key":"10.1002\/14651858.CD011268.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"307-15","DOI":"10.1016\/j.jsmc.2008.01.012","article-title":"Seasonal affective disorder and light therapy","volume":"3","author":"Byrne","year":"2008","journal-title":"Sleep Medicine Clinics"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuroscience.2011.09.036","article-title":"Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues","volume":"197","author":"Ciarleglio","year":"2011","journal-title":"Neuroscience"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2165\/00003495-199753040-00006","article-title":"Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression","volume":"53","author":"Davis","year":"1997","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1586\/14737175.6.9.1249","article-title":"Bupropion: pharmacology and therapeutic applications","volume":"6","author":"Foley","year":"2006","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"11","key":"10.1002\/14651858.CD011268.pub3-BIB0020|cit20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011270.pub2","article-title":"Psychological therapies for preventing seasonal affective disorder","author":"Forneris","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD011268.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2165\/00002018-200831100-00004","article-title":"Comparative risk for harms of second-generation antidepressants: a systematic review and meta-analysis","volume":"31","author":"Gartlehner","year":"2008","journal-title":"Drug Safety"},{"issue":"4","key":"10.1002\/14651858.CD011268.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1176\/appi.ajp.162.4.656","article-title":"The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence","volume":"162","author":"Golden","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0023|cit23","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"4","key":"10.1002\/14651858.CD011268.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011268.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/0272989X08323298","article-title":"Controlling for drug dose in systematic review and meta-analysis: a case study of effect of antidepressant dose","volume":"29","author":"Hansen","year":"2009","journal-title":"Medical Decision Making"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0027|cit27","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"11","key":"10.1002\/14651858.CD011268.pub3-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011271.pub2","article-title":"Melatonin and agomelatine for preventing seasonal affective disorder","author":"Kaminski-Hartenthaler","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9207","key":"10.1002\/14651858.CD011268.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(99)11381-3","article-title":"SNaRIs, NaSSAs, NaRIs: new agents for the treatment of depression","volume":"355","author":"Kent","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD011268.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/ajp.2006.163.5.805","article-title":"The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder","volume":"163","author":"Lam","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD011268.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1017\/S0033291799008570","article-title":"The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment","volume":"29","author":"Leon","year":"1999","journal-title":"Psychological Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011268.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.31887\/DCNS.2007.9.3\/rlevitan","article-title":"The chronobiology and neurobiology of winter seasonal affective disorder","volume":"9","author":"Levitan","year":"2007","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"8","key":"10.1002\/14651858.CD011268.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1017\/S1092852900019593","article-title":"The diagnosis, symptomatology, and epidemiology of seasonal affective disorder","volume":"10","author":"Magnusson","year":"2005","journal-title":"CNS Spectrums"},{"issue":"8","key":"10.1002\/14651858.CD011268.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.biopsych.2005.07.021","article-title":"Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL","volume":"58","author":"Modell","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD011268.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1017\/S1461145701002644","article-title":"Monoaminergic function in the pathogenesis of seasonal affective disorder","volume":"4","author":"Neumeister","year":"2001","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD011268.pub3-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011269.pub2","article-title":"Light therapy for preventing seasonal affective disorder","author":"Nussbaumer","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0038|cit38","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1192\/apt.3.6.352","article-title":"Seasonal affective disorder","volume":"3","author":"Rodin","year":"1997","journal-title":"Advances in Psychiatric Treatment"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-1781(90)90116-M","article-title":"Prevalence of seasonal affective disorder at four latitudes","volume":"31","author":"Rosen","year":"1990","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1037\/0033-2909.86.3.638","article-title":"The \"file-drawer problem\" and tolerance for null results","volume":"86","author":"Rosenthal","year":"1979","journal-title":"Psychological Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD011268.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archpsyc.1984.01790120076010","article-title":"Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy","volume":"41","author":"Rosenthal","year":"1984","journal-title":"Archives of General Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD011268.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1176\/ajp.153.8.1028","article-title":"Winter seasonal affective disorder: a follow-up study of the first 59 patients of the National Institute of Mental Health Seasonal Studies Program","volume":"153","author":"Schwartz","year":"1996","journal-title":"American Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD011268.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1017\/S109285290001960X","article-title":"Update on the biology of seasonal affective disorder","volume":"10","author":"Sohn","year":"2005","journal-title":"CNS Spectrums"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S1092852900024020","article-title":"Mechanism of action of trazodone: a multifunctional drug","volume":"14","author":"Stahl","year":"2009","journal-title":"CNS Spectrums"},{"issue":"12","key":"10.1002\/14651858.CD011268.pub3-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008591.pub2","article-title":"Second-generation antidepressants for seasonal affective disorder","author":"Thaler","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD011268.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0048|cit48","unstructured":"Wells GA Shea B Peterson J Welch V Losos M Tugwell P The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm 2009"},{"issue":"11","key":"10.1002\/14651858.CD011268.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2165\/00023210-200721110-00003","article-title":"Long-term and preventative treatment for seasonal affective disorder","volume":"21","author":"Westrin","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD011268.pub3-BIB0050|cit50","volume-title":"Structured Interview Guide for the Hamilton Depression Rating Scale - Seasonal Affective Disorder version (SIGH-SAD)","author":"Williams","year":"2012"},{"issue":"9","key":"10.1002\/14651858.CD011268.pub3-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011268","article-title":"Second-generation antidepressants for preventing seasonal affective disorder","author":"Gartlehner","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD011268.pub3-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011268.pub2","article-title":"Second-generation antidepressants for preventing seasonal affective disorder in adults","author":"Gartlehner","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011268.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T03:17:09Z","timestamp":1701141429000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011268.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011268.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,18]]}}}